The European Medicines Agency’s scientific guidelines on pharmacogenomics (PG) help medicine developers prepare marketing authorisation applications for human medicines.
If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines.
For a complete list of scientific guidelines currently open for consultation, see Public consultations.
PG considerations during drug life cycle
Guidance on technical PG aspects
Therapeutic-specific PG guidance
How useful is this page?
Average rating:Based on 6 ratings
Add your rating:
- See all ratings
1 ratings0 ratings0 ratings1 ratings4 ratings